Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chewing Ticagrelor vs Prasugrel in STEMI
NCT03016611Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Start
- Feb 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ticagrelor in ST elevation myocardial infarction (STEMI), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03016611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03016611.